A Study of CP-4126 in Patients With Advanced Pancreatic Cancer

Advanced Adenocarcinoma of Pancreas Clinical Trial

Official title: A Phase II Study of CP-4126 in Patients With Advanced Pancreatic Cancer.

Status Completed

Clinical Trial Summary

The main objective of this study is to assess the biological activity of CP-4126 in patients with advanced pancreatic cancer. In addition, the correlation between hENT1 (human equilibrative nucleoside transporter 1) and overall survival will be studied.

Clinical Trial Description

n/a

Study Design

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Adenocarcinoma
• Advanced Adenocarcinoma of Pancreas
• Pancreatic Neoplasms

• NCT number: NCT00913198
• Study type: Interventional
• Source: Clavis Pharma
• Status: Completed
• Phase: Phase 2
• Start date: April 2009
• Completion date: September 2011